EP1283897A4 - Für stargardt-ähnliche, dominante, makula-dystrophy verantwortliches gen - Google Patents

Für stargardt-ähnliche, dominante, makula-dystrophy verantwortliches gen

Info

Publication number
EP1283897A4
EP1283897A4 EP01935445A EP01935445A EP1283897A4 EP 1283897 A4 EP1283897 A4 EP 1283897A4 EP 01935445 A EP01935445 A EP 01935445A EP 01935445 A EP01935445 A EP 01935445A EP 1283897 A4 EP1283897 A4 EP 1283897A4
Authority
EP
European Patent Office
Prior art keywords
stargardt
macular dystrophy
gene responsible
dominant macular
dominant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01935445A
Other languages
English (en)
French (fr)
Other versions
EP1283897A2 (de
Inventor
Konstantin Petrukhin
Wen Li
Kang Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Merck and Co Inc
Original Assignee
Johns Hopkins University
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, Merck and Co Inc filed Critical Johns Hopkins University
Publication of EP1283897A2 publication Critical patent/EP1283897A2/de
Publication of EP1283897A4 publication Critical patent/EP1283897A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP01935445A 2000-05-16 2001-05-11 Für stargardt-ähnliche, dominante, makula-dystrophy verantwortliches gen Withdrawn EP1283897A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20499000P 2000-05-16 2000-05-16
US204990P 2000-05-16
PCT/US2001/015464 WO2001087921A2 (en) 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy

Publications (2)

Publication Number Publication Date
EP1283897A2 EP1283897A2 (de) 2003-02-19
EP1283897A4 true EP1283897A4 (de) 2004-08-04

Family

ID=22760322

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01935445A Withdrawn EP1283897A4 (de) 2000-05-16 2001-05-11 Für stargardt-ähnliche, dominante, makula-dystrophy verantwortliches gen

Country Status (3)

Country Link
EP (1) EP1283897A4 (de)
CA (1) CA2409705A1 (de)
WO (1) WO2001087921A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221404B2 (en) * 2000-11-29 2008-01-03 Xenon Genetics Inc Human elongase genes and uses thereof
EP3629022A1 (de) 2008-07-25 2020-04-01 Richard W. Wagner Proteinscreeningverfahren
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
US9637450B2 (en) 2013-03-14 2017-05-02 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
EP3495357B1 (de) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phenylpiperidine, deren herstellung und verwendung
BR112016025356B1 (pt) 2014-04-30 2023-04-18 The Trustees Of Columbia University In The City Of New York Compostos de 4-fenilpiperidinas substituídas, composições e seus usos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 7 March 2000 (2000-03-07), SIMS S, XP002283261, retrieved from EMBL Database accession no. AL159162 *
EDWARDS A O ET AL: "Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14.", AMERICAN JOURNAL OF OPHTHALMOLOGY. UNITED STATES APR 1999, vol. 127, no. 4, April 1999 (1999-04-01), pages 426 - 435, XP002283260, ISSN: 0002-9394 *

Also Published As

Publication number Publication date
WO2001087921A2 (en) 2001-11-22
EP1283897A2 (de) 2003-02-19
WO2001087921A3 (en) 2002-03-14
CA2409705A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
DE60130517D1 (de) Integriertes Sichtsystem
MA27083A1 (fr) Derives de nicotine ou d'isonicotine benzothiazole
ITVR20010019A0 (it) "contrafforte per calzature"
MA26816A1 (fr) Derives d'amino-triazolopyridine
DK1412328T3 (da) Dolastatin-10-derivater
DE60128764D1 (de) Schwingende Hinterradfederung
AU2002352953A1 (en) Support garment for quadrupeds
DE60012046D1 (de) Metallischer luftsack
AUPR364401A0 (en) Garment hanger
EP1283897A4 (de) Für stargardt-ähnliche, dominante, makula-dystrophy verantwortliches gen
FR2833596B1 (fr) Procede de preparation de derives d'echinocandine
FR2807389B1 (fr) Mat de suspension profile de voilure d'aeronef
EP1153612A4 (de) Verstarker von antikrebs mitteln
DE50008537D1 (de) Mikromechanischer drehratensensor
MA27240A1 (fr) Derives d'imidazoquinoleine
EP1426319A4 (de) Positionsdetektor für aufzug
AU2002341044A1 (en) Methods for detecting parkinson's disease
GB0121098D0 (en) Garment hangers
DE50003442D1 (de) Kleiderbügel
FI20030531A7 (fi) Teurastajan työkalu
GB2378130B (en) Garment hanger
UA5636S (uk) Плащ чоловічий
FI4068U1 (fi) Suojapuku
ATE470381T1 (de) Aufhänger
UA5887S (uk) Пальто жіноче демісезонне

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021216

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 B

Ipc: 7C 12P 21/06 A

Ipc: 7C 07K 14/47 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61P 27/00 B

Ipc: 7C 12N 1/20 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040622

17Q First examination report despatched

Effective date: 20090204

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090815